# SATB1

## Overview
SATB1, or Special AT-rich Sequence Binding Protein 1, is a gene that encodes the SATB homeobox 1 protein, a transcription factor and chromatin organizer crucial for gene regulation and chromatin structure organization. The SATB1 protein is characterized by its ability to bind to specific DNA sequences and organize chromatin into loop domains, thereby influencing the accessibility and activity of various genes. This protein is particularly significant in thymocytes, where it plays a vital role in T cell development by structuring chromatin to regulate gene expression crucial for cell differentiation (Cai2003Tissue-specific). SATB1's functionality is modulated through various post-translational modifications and interactions with other proteins, which collectively contribute to its role in normal cellular processes and disease states, including cancer and autoimmune diseases (Will2013Satb1; Luo2019Decreased).

## Structure
The SATB1 protein, encoded by the SATB homeobox 1 gene, exhibits a complex molecular structure integral to its function in chromatin organization and gene regulation. The protein is characterized by several distinct domains that facilitate its DNA-binding and regulatory activities. The N-terminal domain of SATB1 contains a ubiquitin-like domain (ULD), which is crucial for the oligomerization of the protein into a tetramer, a quaternary structure essential for high-affinity DNA binding (Wang2014Crystal; Wang2012The). This tetramerization supports SATB1's role in organizing the genome and modulating gene expression.

Additionally, SATB1 features tandem CUT domains and a homeodomain. The CUT domains, particularly the CUT1 and CUT2, are involved in recognizing core unwinding elements in matrix attachment regions (MARs), while the homeodomain binds DNA with lower specificity and affinity (Wang2014Crystal; Dickinson1997An). The presence of a PDZ-like domain in the N-terminal region also contributes to DNA binding and chromatin interactions through homodimerization (Purbey2008PDZ).

Post-translational modifications such as phosphorylation, acetylation, and sumoylation regulate SATB1's transcriptional activity, influencing its interaction with chromatin remodeling/modifying enzymes and transcription factors (Wang2014Crystal; Wang2012The). Furthermore, splice variant isoforms of SATB1 have been identified, which may lead to functional differences within the cell. These isoforms include a long isoform consisting of 795 amino acids and a short isoform with 764 amino acids, with the long isoform containing an extra peptide of 31 amino acids (Zelenka2023A). These structural features and modifications collectively enable SATB1 to play a pivotal role in gene expression regulation and chromatin structure organization.

## Function
SATB1 (Special AT-rich Sequence Binding Protein 1) is a transcription factor and chromatin organizer that plays a pivotal role in the regulation of gene expression by structuring chromatin into loop domains. This organization facilitates or restricts the access of transcriptional machinery to specific gene regions, thereby influencing gene activity. SATB1 is particularly active in thymocytes, where it forms a unique cage-like network that encompasses heterochromatin and tethers specific DNA sequences. This tethering is crucial for the proper regulation of genes involved in thymocyte differentiation and T cell development (Cai2003Tissue-specific).

In the nucleus of thymocytes, SATB1 binds to base-unpairing regions (BURs) on DNA, which are essential for its function in gene regulation. This binding leads to changes in histone modification patterns, such as switching from methylation to acetylation at Lys9 of histone H3, thereby influencing chromatin structure and gene expression over long distances (Cai2003Tissue-specific). Furthermore, SATB1 recruits various chromatin-remodeling complexes to these sites, enhancing or repressing gene expression as needed (Cai2003Tissue-specific).

The function of SATB1 extends beyond the thymus, as it also impacts the differentiation of other hematopoietic lineages and embryonic stem cells by controlling the expression of transcriptional master regulators such as Sfpi1 and Nanog (Will2013Satb1). Additionally, SATB1's dysfunction is linked to certain types of cancer, highlighting its significant role in both normal cell function and disease (Will2013Satb1).

## Clinical Significance
SATB1 (SATB homeobox 1) is implicated in various diseases, particularly in cancer, where its expression levels and mutations significantly influence disease progression and prognosis. In several cancers, including breast, colorectal, prostate, liver, bladder, ovarian, and others, SATB1 is frequently overexpressed, correlating with aggressive tumor phenotypes, poor differentiation, larger tumor size, and poor prognosis (FrÃ¶mberg2018The; Glatzel-PluciÅska2019The). Specifically, in breast cancer, high levels of SATB1 expression are associated with poor tumor differentiation, higher TNM stage, and the presence of lymph node metastasis, making it a potential prognostic marker (Glatzel-PluciÅska2019The; Hanker2011SATB1).

Furthermore, SATB1 plays a role in hematological malignancies. In acute myeloid leukemia (AML) and T cell leukemia/lymphoma, decreased SATB1 expression contrasts with its behavior in solid tumors, suggesting a tumor-suppressive role in these conditions (Luo2019Decreased). Alterations in SATB1 expression also affect immune regulation, where its dysregulation is linked to autoimmune diseases due to its role in T-cell development and regulatory T cell function (Sunkara2018Functional).

These findings underscore the complex roles of SATB1 in various pathologies, highlighting its potential as a target for therapeutic intervention and as a biomarker for disease prognosis.

## Interactions
SATB1 interacts with a variety of proteins and nucleic acids, playing a significant role in chromatin organization and transcription regulation. One of its key interactions is with CtBP1, a transcriptional co-repressor. This interaction is mediated through a specific motif within SATB1's PDZ-like domain and is influenced by the acetylation status of lysine 136 (K136), which can enhance or reduce this association depending on its acetylation state (Purbey2009Acetylation-Dependent). Additionally, SATB1 forms complexes with HDAC1, another transcriptional repressor, which further contributes to the transcriptional repression activities of SATB1 (Purbey2009Acetylation-Dependent).

SATB1 also binds to matrix attachment regions (MARs) in DNA, which are crucial for its role in organizing chromatin into loops and influencing gene transcription. This binding ability is essential for SATB1's function in chromatin architecture and gene regulation (Tan2008SUMO). Furthermore, SATB1 undergoes sumoylation, which targets it to promyelocytic leukemia nuclear bodies and affects its interaction with DNA and other proteins during processes like apoptosis (Tan2008SUMO).

In the context of T-cell apoptosis, SATB1 is cleaved by caspase-6, disrupting its PDZ domain-mediated dimerization and detaching it from chromatin, which is a critical step in the apoptotic process (Galande2001SATB1). This interaction highlights the dynamic nature of SATB1's role in cellular processes, where its structural integrity and binding capabilities are modulated by post-translational modifications and interactions with other cellular components.


## References


[1. (Will2013Satb1) Britta Will, Thomas O Vogler, Boris Bartholdy, Francine Garrett-Bakelman, Jillian Mayer, Laura Barreyro, Ashley Pandolfi, Tihomira I Todorova, Ujunwa C Okoye-Okafor, Robert F Stanley, Tushar D Bhagat, Amit Verma, Maria E Figueroa, Ari Melnick, Michael Roth, and Ulrich Steidl. Satb1 regulates the self-renewal of hematopoietic stem cells by promoting quiescence and repressing differentiation commitment. Nature Immunology, 14(5):437â445, April 2013. URL: http://dx.doi.org/10.1038/ni.2572, doi:10.1038/ni.2572. (88 citations) 10.1038/ni.2572](https://doi.org/10.1038/ni.2572)

[2. (Luo2019Decreased) Xiaodan Luo, Lihua Xu, Xiaohong Wu, Huo Tan, and Lian Liu. Decreased satb1 expression promotes aml cell proliferation through nf-Îºb activation. Cancer Cell International, May 2019. URL: http://dx.doi.org/10.1186/s12935-019-0850-x, doi:10.1186/s12935-019-0850-x. (5 citations) 10.1186/s12935-019-0850-x](https://doi.org/10.1186/s12935-019-0850-x)

[3. (Glatzel-PluciÅska2019The) Glatzel-PluciÅska, Piotrowska, DziÄgiel, and Podhorska-OkoÅÃ³w. The role of satb1 in tumour progression and metastasis. International Journal of Molecular Sciences, 20(17):4156, August 2019. URL: http://dx.doi.org/10.3390/ijms20174156, doi:10.3390/ijms20174156. (23 citations) 10.3390/ijms20174156](https://doi.org/10.3390/ijms20174156)

[4. (Wang2012The) Zheng Wang, Xue Yang, Xinlei Chu, Jinxiu Zhang, Hao Zhou, Yuequan Shen, and Jiafu Long. The structural basis for the oligomerization of the n-terminal domain of satb1. Nucleic Acids Research, 40(9):4193â4202, January 2012. URL: http://dx.doi.org/10.1093/nar/gkr1284, doi:10.1093/nar/gkr1284. (47 citations) 10.1093/nar/gkr1284](https://doi.org/10.1093/nar/gkr1284)

[5. (Purbey2008PDZ) Prabhat Kumar Purbey, Sunita Singh, P. Pavan Kumar, Sameet Mehta, K. N. Ganesh, Debashis Mitra, and Sanjeev Galande. Pdz domain-mediated dimerization and homeodomain-directed specificity are required for high-affinity dna binding by satb1. Nucleic Acids Research, 36(7):2107â2122, January 2008. URL: http://dx.doi.org/10.1093/nar/gkm1151, doi:10.1093/nar/gkm1151. (33 citations) 10.1093/nar/gkm1151](https://doi.org/10.1093/nar/gkm1151)

[6. (Cai2003Tissue-specific) Shutao Cai, Hye-Jung Han, and Terumi Kohwi-Shigematsu. Tissue-specific nuclear architecture and gene expession regulated by satb1. Nature Genetics, 34(1):42â51, April 2003. URL: http://dx.doi.org/10.1038/ng1146, doi:10.1038/ng1146. (536 citations) 10.1038/ng1146](https://doi.org/10.1038/ng1146)

[7. (Hanker2011SATB1) Lars C. Hanker, Thomas Karn, Loreta Mavrova-Risteska, Eugen RuckhÃ¤berle, Regine Gaetje, Uwe Holtrich, Manfred Kaufmann, Achim Rody, and Inka Wiegratz. Satb1 gene expression and breast cancer prognosis. The Breast, 20(4):309â313, August 2011. URL: http://dx.doi.org/10.1016/j.breast.2010.10.002, doi:10.1016/j.breast.2010.10.002. (56 citations) 10.1016/j.breast.2010.10.002](https://doi.org/10.1016/j.breast.2010.10.002)

[8. (Tan2008SUMO) Joseph-Anthony T. Tan, Yujie Sun, Jing Song, Yuan Chen, Theodore G. Krontiris, and Linda K. Durrin. Sumo conjugation to the matrix attachment region-binding protein, special at-rich sequence-binding protein-1 (satb1), targets satb1 to promyelocytic nuclear bodies where it undergoes caspase cleavage. Journal of Biological Chemistry, 283(26):18124â18134, June 2008. URL: http://dx.doi.org/10.1074/jbc.m800512200, doi:10.1074/jbc.m800512200. (51 citations) 10.1074/jbc.m800512200](https://doi.org/10.1074/jbc.m800512200)

[9. (Galande2001SATB1) Sanjeev Galande, Liliane A. Dickinson, I. Saira Mian, Marianna Sikorska, and Terumi Kohwi-Shigematsu. Satb1 cleavage by caspase 6 disrupts pdz domain-mediated dimerization, causing detachment from chromatin early in t-cell apoptosis. Molecular and Cellular Biology, 21(16):5591â5604, August 2001. URL: http://dx.doi.org/10.1128/mcb.21.16.5591-5604.2001, doi:10.1128/mcb.21.16.5591-5604.2001. (103 citations) 10.1128/mcb.21.16.5591-5604.2001](https://doi.org/10.1128/mcb.21.16.5591-5604.2001)

[10. (Dickinson1997An) Liliane A. Dickinson, Craig D. Dickinson, and Terumi Kohwi-Shigematsu. An atypical homeodomain in satb1 promotes specific recognition of the key structural element in a matrix attachment region. Journal of Biological Chemistry, 272(17):11463â11470, April 1997. URL: http://dx.doi.org/10.1074/jbc.272.17.11463, doi:10.1074/jbc.272.17.11463. (174 citations) 10.1074/jbc.272.17.11463](https://doi.org/10.1074/jbc.272.17.11463)

[11. (Purbey2009Acetylation-Dependent) Prabhat Kumar Purbey, Sunita Singh, Dimple Notani, P. Pavan Kumar, Amita S. Limaye, and Sanjeev Galande. Acetylation-dependent interaction of satb1 and ctbp1 mediates transcriptional repression by satb1. Molecular and Cellular Biology, 29(5):1321â1337, March 2009. URL: http://dx.doi.org/10.1128/mcb.00822-08, doi:10.1128/mcb.00822-08. (52 citations) 10.1128/mcb.00822-08](https://doi.org/10.1128/mcb.00822-08)

[12. (Wang2014Crystal) Zheng Wang, Xue Yang, Shuang Guo, Yin Yang, Xun-Cheng Su, Yuequan Shen, and Jiafu Long. Crystal structure of the ubiquitin-like domain-cut repeat-like tandem of special at-rich sequence binding protein 1 (satb1) reveals a coordinating dna-binding mechanism. Journal of Biological Chemistry, 289(40):27376â27385, October 2014. URL: http://dx.doi.org/10.1074/jbc.m114.562314, doi:10.1074/jbc.m114.562314. (27 citations) 10.1074/jbc.m114.562314](https://doi.org/10.1074/jbc.m114.562314)

[13. (FrÃ¶mberg2018The) Anja FrÃ¶mberg, Kurt Engeland, and Achim Aigner. The special at-rich sequence binding protein 1 (satb1) and its role in solid tumors. Cancer Letters, 417:96â111, March 2018. URL: http://dx.doi.org/10.1016/j.canlet.2017.12.031, doi:10.1016/j.canlet.2017.12.031. (29 citations) 10.1016/j.canlet.2017.12.031](https://doi.org/10.1016/j.canlet.2017.12.031)

[14. (Sunkara2018Functional) Krishna P. Sunkara, Gaurav Gupta, Philip M. Hansbro, Kamal Dua, and Mary Bebawy. Functional relevance of satb1 in immune regulation and tumorigenesis. Biomedicine &amp; Pharmacotherapy, 104:87â93, August 2018. URL: http://dx.doi.org/10.1016/j.biopha.2018.05.045, doi:10.1016/j.biopha.2018.05.045. (47 citations) 10.1016/j.biopha.2018.05.045](https://doi.org/10.1016/j.biopha.2018.05.045)

[15. (Zelenka2023A) Tomas Zelenka, Dionysios-Alexandros Papamatheakis, Petros Tzerpos, Giorgos Panagopoulos, Konstantinos C. Tsolis, Vassilis M. Papadakis, Dimitris Mariatos Metaxas, George Papadogkonas, Eleftherios Mores, Manouela Kapsetaki, Joseph Papamatheakis, David Stanek, and Charalampos Spilianakis. A novel satb1 protein isoform with different biophysical properties. Frontiers in Cell and Developmental Biology, August 2023. URL: http://dx.doi.org/10.3389/fcell.2023.1242481, doi:10.3389/fcell.2023.1242481. (1 citations) 10.3389/fcell.2023.1242481](https://doi.org/10.3389/fcell.2023.1242481)